Diffuse panbronchiolitis pathophysiology: Difference between revisions
mNo edit summary |
|||
| (4 intermediate revisions by one other user not shown) | |||
| Line 2: | Line 2: | ||
{{Diffuse panbronchiolitis}} | {{Diffuse panbronchiolitis}} | ||
{{CMG}} | {{CMG}} {{AE}} | ||
==Overview== | ==Overview== | ||
| Line 8: | Line 8: | ||
==Pathophysiology== | ==Pathophysiology== | ||
DPB remains idiopathic, which means an exact [[physiological]], [[Environment (biophysical)|environment]]al, or [[pathogen]]ic cause of the disease is unknown.<ref name=dpb06>{{cite journal |author=Poletti V, Casoni G, Chilosi M, Zompatori M |title=Diffuse panbronchiolitis |journal=Eur Respir J. |volume=28 |issue=4 |pages=862-871 |year=2006 |pmid=17012632 }}</ref> However, several known factors are involved with the pathogenesis of DPB.<ref name=hla98>{{cite journal |author=Keicho N, Tokunaga K, Nakata K, Taguchi Y, Azuma A, Bannai M, Emi M, Ohishi N, Yazaki Y, Kudoh S |title=Contribution of HLA genes in genetic predisposition for diffuse panbronchiolitis |journal=Am J Respir Crit Care Med. |volume=158 |issue=3 |pages=846-850 |year=1998 |pmid=9731015 }}</ref><ref name=hla99/> | DPB remains idiopathic, which means an exact [[physiological]], [[Environment (biophysical)|environment]]al, or [[pathogen]]ic cause of the disease is unknown.<ref name=dpb06>{{cite journal |author=Poletti V, Casoni G, Chilosi M, Zompatori M |title=Diffuse panbronchiolitis |journal=Eur Respir J. |volume=28 |issue=4 |pages=862-871 |year=2006 |pmid=17012632 }}</ref> However, several known factors are involved with the pathogenesis of DPB.<ref name=hla98>{{cite journal |author=Keicho N, Tokunaga K, Nakata K, Taguchi Y, Azuma A, Bannai M, Emi M, Ohishi N, Yazaki Y, Kudoh S |title=Contribution of HLA genes in genetic predisposition for diffuse panbronchiolitis |journal=Am J Respir Crit Care Med. |volume=158 |issue=3 |pages=846-850 |year=1998 |pmid=9731015 }}</ref><ref name=hla99>{{cite journal |author=Park MH, Kim YW, Yoon HI, Yoo CD, Han SK, Shim YS, Kim WD |title=Association of HLA class I antigens with diffuse panbronchiolitis in Korean patients |journal=Am J Respir Crit Care Med. |volume=159 |issue=2 |pages=526-529 |year=1999 |pmid=9927368 }}</ref> | ||
The [[major histocompatibility complex]] (MHC) is a large [[genome|genomic]] region found in most [[vertebrate]]s, that is associated with [[mating]] and the [[immune system]]. It is located on [[chromosome 6]] in humans. A subset of the human MHC is [[human leukocyte antigen]] (HLA), which controls the [[antigen presentation|antigen presenting system]], as part of [[adaptive immunity]] against [[pathogen]]s such as [[bacteria]] and [[virus]]es. | The [[major histocompatibility complex]] (MHC) is a large [[genome|genomic]] region found in most [[vertebrate]]s, that is associated with [[mating]] and the [[immune system]]. It is located on [[chromosome 6]] in humans. A subset of the human MHC is [[human leukocyte antigen]] (HLA), which controls the [[antigen presentation|antigen presenting system]], as part of [[adaptive immunity]] against [[pathogen]]s such as [[bacteria]] and [[virus]]es. | ||
Genetic predisposition for DPB has been localized to two HLA [[haplotype]]s unique to Asians, particularly of East Asian descent.<ref name=hla98/><ref name=hla00/> [[HLA-B54]] is associated with DPB in Japanese patients,<ref name=hla98>{{cite journal |author=Keicho N, Tokunaga K, Nakata K, Taguchi Y, Azuma A, Bannai M, Emi M, Ohishi N, Yazaki Y, Kudoh S |title=Contribution of HLA genes in genetic predisposition for diffuse panbronchiolitis |journal=Am J Respir Crit Care Med. |volume=158 |issue=3 |pages=846-850 |year=1998 |pmid=9731015 }}</ref> while [[HLA-A11]] is associated with the disease in Koreans.<ref name=hla99/> One or more [[candidate gene]]s<ref name=orf>{{cite journal |author=Matsuzaka Y, Tounai K, Denda A, Tomizawa M, Makino S, Okamoto K, Keicho N, Oka A, Kulski JK, Tamiya G, Inoko H |title=Identification of novel candidate genes in the diffuse panbronchiolitis critical region of the class I human MHC |journal=Immunogenetics |volume=54 |issue=5 |pages=301-309 |year=2002 |pmid=12185533 }}</ref> (a gene suspected to be responsible for a trait or disease) within this region of [[human leukocyte antigen|class I HLA]] are believed to be the genetic factor responsible for DPB, allowing disease susceptibility<ref name=hla00/> related to the structure of the [[antigen presentation|antigen presenting]] [[molecules]] selected by these genes.<ref name=tap>{{cite journal |author=Keicho N, Tokunaga K, Nakata K, Taguchi Y, Azuma A, Tanabe K, Matsushita M, Emi M, Ohishi N, Kudoh S |title=Contribution of TAP genes to genetic predisposition for diffuse panbronchiolitis |journal=Tissue Antigens |volume=53 |issue=4 pt. 1 |pages=366-373 |year=1999 |pmid=10323341 }}</ref> | Genetic predisposition for DPB has been localized to two HLA [[haplotype]]s unique to Asians, particularly of East Asian descent.<ref name=hla98/><ref name=hla00>{{cite journal |author=Keicho N, Ohashi J, Tamiya G, Nakata K, Taguchi Y, Azuma A, Ohishi N, Emi M, Park MH, Inoko H, Tokunaga K, Kudoh S |title=Fine localization of a major disease-susceptibility locus for diffuse panbronchiolitis |journal=Am J Hum Genet. |volume=66 |issue=2 |pages=501-507 |year=2000 |pmid=10677310 }}</ref> [[HLA-B54]] is associated with DPB in Japanese patients,<ref name=hla98>{{cite journal |author=Keicho N, Tokunaga K, Nakata K, Taguchi Y, Azuma A, Bannai M, Emi M, Ohishi N, Yazaki Y, Kudoh S |title=Contribution of HLA genes in genetic predisposition for diffuse panbronchiolitis |journal=Am J Respir Crit Care Med. |volume=158 |issue=3 |pages=846-850 |year=1998 |pmid=9731015 }}</ref> while [[HLA-A11]] is associated with the disease in Koreans.<ref name=hla99>{{cite journal |author=Park MH, Kim YW, Yoon HI, Yoo CD, Han SK, Shim YS, Kim WD |title=Association of HLA class I antigens with diffuse panbronchiolitis in Korean patients |journal=Am J Respir Crit Care Med. |volume=159 |issue=2 |pages=526-529 |year=1999 |pmid=9927368 }}</ref> One or more [[candidate gene]]s<ref name=orf>{{cite journal |author=Matsuzaka Y, Tounai K, Denda A, Tomizawa M, Makino S, Okamoto K, Keicho N, Oka A, Kulski JK, Tamiya G, Inoko H |title=Identification of novel candidate genes in the diffuse panbronchiolitis critical region of the class I human MHC |journal=Immunogenetics |volume=54 |issue=5 |pages=301-309 |year=2002 |pmid=12185533 }}</ref> (a gene suspected to be responsible for a trait or disease) within this region of [[human leukocyte antigen|class I HLA]] are believed to be the genetic factor responsible for DPB, allowing disease susceptibility<ref name=hla00/> related to the structure of the [[antigen presentation|antigen presenting]] [[molecules]] selected by these genes.<ref name=tap>{{cite journal |author=Keicho N, Tokunaga K, Nakata K, Taguchi Y, Azuma A, Tanabe K, Matsushita M, Emi M, Ohishi N, Kudoh S |title=Contribution of TAP genes to genetic predisposition for diffuse panbronchiolitis |journal=Tissue Antigens |volume=53 |issue=4 pt. 1 |pages=366-373 |year=1999 |pmid=10323341 }}</ref> | ||
Candidate genes within HLA that are most likely involved with DPB suceptibility include: [[FAM46A|C6orf37]]<ref name=orf/> and [[TAP2]].<ref name=tap/> | Candidate genes within HLA that are most likely involved with DPB suceptibility include: [[FAM46A|C6orf37]]<ref name=orf/> and [[TAP2]].<ref name=tap/> | ||
| Line 19: | Line 19: | ||
located on [[chromosome 4]]. The role of IL-8 to produce inflammation by causing the proliferation of neutrophil granulocytes at any site of pathogenic involvement, in conjunction with strong [[microsatellite]] identification with DPB, implicates IL-8 as another candidate gene associated with DPB pathogenesis.<ref name=il8/> This also supports the idea that several factors, including those unrelated to HLA as well as non-genetic, and unknown factors, may cause the disease.<ref name=il8/> | located on [[chromosome 4]]. The role of IL-8 to produce inflammation by causing the proliferation of neutrophil granulocytes at any site of pathogenic involvement, in conjunction with strong [[microsatellite]] identification with DPB, implicates IL-8 as another candidate gene associated with DPB pathogenesis.<ref name=il8/> This also supports the idea that several factors, including those unrelated to HLA as well as non-genetic, and unknown factors, may cause the disease.<ref name=il8/> | ||
The inflammation common to DPB also provides a means to determine other mechanisms of disease pathogenesis.<ref name=cd8>{{cite journal |author=Kadota J, Mukae H, Tomono K, Kohno S |title=High concentrations of beta-chemokines in BAL fluid of patients with diffuse panbronchiolitis |journal=Chest |volume=120 |issue=2 |pages=602-607 |year=2001 |pmid=11502665 }}</ref> This may be partly due to the persistence of inflammation in DPB, with ''or'' without the presence of the two opportunistic bacteria sometimes found with the disease (''haemophilus influenzae'', ''pseudomonas aeruginosa'').<ref name=path/> Inflammation caused by the [[chemokine]] [[CCL4|MIP-1alpha]] and its involvement with [[CD8|CD8+]] [[T-cell]]s is believed to be one such mechanism of DPB pathogenesis.<ref name=cd8/> | The inflammation common to DPB also provides a means to determine other mechanisms of disease pathogenesis.<ref name=cd8>{{cite journal |author=Kadota J, Mukae H, Tomono K, Kohno S |title=High concentrations of beta-chemokines in BAL fluid of patients with diffuse panbronchiolitis |journal=Chest |volume=120 |issue=2 |pages=602-607 |year=2001 |pmid=11502665 }}</ref> This may be partly due to the persistence of inflammation in DPB, with ''or'' without the presence of the two opportunistic bacteria sometimes found with the disease (''haemophilus influenzae'', ''pseudomonas aeruginosa'').<ref name=path>{{cite journal |author=Yanagihara K, Kadoto J, Kohno S |title=Diffuse panbronchiolitis--pathophysiology and treatment mechanisms |journal=Int J Antimicrob Agents |volume=18 |issue=Suppl. 1 |pages=S83-87 |year=2001 |pmid=11574201 }}</ref> Inflammation caused by the [[chemokine]] [[CCL4|MIP-1alpha]] and its involvement with [[CD8|CD8+]] [[T-cell]]s is believed to be one such mechanism of DPB pathogenesis.<ref name=cd8/> | ||
Other factors found with DPB play a part in its pathogenesis by sometimes causing minor variations of it. | Other factors found with DPB play a part in its pathogenesis by sometimes causing minor variations of it. | ||
| Line 29: | Line 29: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Pulmonology]] | |||
{{WH}} | |||
{{WS}} | |||
Latest revision as of 14:14, 6 June 2016
|
Diffuse panbronchiolitis Microchapters |
|
Differentiating Diffuse panbronchiolitis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Diffuse panbronchiolitis pathophysiology On the Web |
|
American Roentgen Ray Society Images of Diffuse panbronchiolitis pathophysiology |
|
Risk calculators and risk factors for Diffuse panbronchiolitis pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Pathophysiology
DPB remains idiopathic, which means an exact physiological, environmental, or pathogenic cause of the disease is unknown.[1] However, several known factors are involved with the pathogenesis of DPB.[2][3]
The major histocompatibility complex (MHC) is a large genomic region found in most vertebrates, that is associated with mating and the immune system. It is located on chromosome 6 in humans. A subset of the human MHC is human leukocyte antigen (HLA), which controls the antigen presenting system, as part of adaptive immunity against pathogens such as bacteria and viruses.
Genetic predisposition for DPB has been localized to two HLA haplotypes unique to Asians, particularly of East Asian descent.[2][4] HLA-B54 is associated with DPB in Japanese patients,[2] while HLA-A11 is associated with the disease in Koreans.[3] One or more candidate genes[5] (a gene suspected to be responsible for a trait or disease) within this region of class I HLA are believed to be the genetic factor responsible for DPB, allowing disease susceptibility[4] related to the structure of the antigen presenting molecules selected by these genes.[6]
Candidate genes within HLA that are most likely involved with DPB suceptibility include: C6orf37[5] and TAP2.[6]
Another such gene, though not a part of the HLA system, is the gene for interleukin 8 (IL-8)[7] located on chromosome 4. The role of IL-8 to produce inflammation by causing the proliferation of neutrophil granulocytes at any site of pathogenic involvement, in conjunction with strong microsatellite identification with DPB, implicates IL-8 as another candidate gene associated with DPB pathogenesis.[7] This also supports the idea that several factors, including those unrelated to HLA as well as non-genetic, and unknown factors, may cause the disease.[7]
The inflammation common to DPB also provides a means to determine other mechanisms of disease pathogenesis.[8] This may be partly due to the persistence of inflammation in DPB, with or without the presence of the two opportunistic bacteria sometimes found with the disease (haemophilus influenzae, pseudomonas aeruginosa).[9] Inflammation caused by the chemokine MIP-1alpha and its involvement with CD8+ T-cells is believed to be one such mechanism of DPB pathogenesis.[8]
Other factors found with DPB play a part in its pathogenesis by sometimes causing minor variations of it.
Beta defensins, a family of antimicrobial peptides found in the respiratory tract, are responsible for further inflammation in DPB, when associated pathogens like pseudomonas aerugenosa are present.[10]
If present in a DPB patient, the human T-lymphotropic virus, type I, a retrovirus, modifies DPB pathogenesis by infecting CD4+ cells (Helper T-cells) and altering there effectiveness in reducing both known and unknown pathogenic involvement with DPB.[11] Conversely, an onset of DPB causes increased frequency of Adult T-cell leukemia in human lymphotropic virus sufferers.[11]
References
- ↑ Poletti V, Casoni G, Chilosi M, Zompatori M (2006). "Diffuse panbronchiolitis". Eur Respir J. 28 (4): 862–871. PMID 17012632.
- ↑ 2.0 2.1 2.2 Keicho N, Tokunaga K, Nakata K, Taguchi Y, Azuma A, Bannai M, Emi M, Ohishi N, Yazaki Y, Kudoh S (1998). "Contribution of HLA genes in genetic predisposition for diffuse panbronchiolitis". Am J Respir Crit Care Med. 158 (3): 846–850. PMID 9731015.
- ↑ 3.0 3.1 Park MH, Kim YW, Yoon HI, Yoo CD, Han SK, Shim YS, Kim WD (1999). "Association of HLA class I antigens with diffuse panbronchiolitis in Korean patients". Am J Respir Crit Care Med. 159 (2): 526–529. PMID 9927368.
- ↑ 4.0 4.1 Keicho N, Ohashi J, Tamiya G, Nakata K, Taguchi Y, Azuma A, Ohishi N, Emi M, Park MH, Inoko H, Tokunaga K, Kudoh S (2000). "Fine localization of a major disease-susceptibility locus for diffuse panbronchiolitis". Am J Hum Genet. 66 (2): 501–507. PMID 10677310.
- ↑ 5.0 5.1 Matsuzaka Y, Tounai K, Denda A, Tomizawa M, Makino S, Okamoto K, Keicho N, Oka A, Kulski JK, Tamiya G, Inoko H (2002). "Identification of novel candidate genes in the diffuse panbronchiolitis critical region of the class I human MHC". Immunogenetics. 54 (5): 301–309. PMID 12185533.
- ↑ 6.0 6.1 Keicho N, Tokunaga K, Nakata K, Taguchi Y, Azuma A, Tanabe K, Matsushita M, Emi M, Ohishi N, Kudoh S (1999). "Contribution of TAP genes to genetic predisposition for diffuse panbronchiolitis". Tissue Antigens. 53 (4 pt. 1): 366–373. PMID 10323341.
- ↑ 7.0 7.1 7.2 Emi M, Keicho N, Tokunaga K, Katsumata H, Souma S, Nakata K, Taguchi Y, Ohishi N, Azuma A, Kudoh S (1999). "Association of diffuse panbronchiolitis with microsatellite polymorphisms of the human interleukin 8 (IL-8) gene". J Hum Genet. 44 (3): 169–172. PMID 10319580.
- ↑ 8.0 8.1 Kadota J, Mukae H, Tomono K, Kohno S (2001). "High concentrations of beta-chemokines in BAL fluid of patients with diffuse panbronchiolitis". Chest. 120 (2): 602–607. PMID 11502665.
- ↑ Yanagihara K, Kadoto J, Kohno S (2001). "Diffuse panbronchiolitis--pathophysiology and treatment mechanisms". Int J Antimicrob Agents. 18 (Suppl. 1): S83–87. PMID 11574201.
- ↑ Hiratsuka T, Mukae H, Iiboshi H, Ashitani J, Nabeshima K, Minematsu T, Chino N, Ihi T, Kohno S, Nakazato M (2003). "Increased concentrations of human beta-defensins in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis". Thorax. 58 (5): 425–430. PMID 12728165.
- ↑ 11.0 11.1 Yamamoto M, Matsuyama W, Oonakahara K, Watanabe M, Higashimoto I, Kawabata M, Osame M, Arimura K (2004). "Influence of human T lymphotropic virus type I on diffuse pan-bronchiolitis". Clin Exp Immunol. 136 (3): 513–520. PMID 15147354.